UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 531

Sortiert nach

The Multidimensional Challenge of Treating Coronavirus Disease 2019 (COVID-19): Remdesivir Is a Foot in the Door

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4175-e4178

Gandhi, Rajesh T

2021

Link zum Volltext

Verfügbarkeit prüfen

Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

Annals of internal medicine, 2021-01, Vol.174 (1), p.69

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 Therapeutics for Nonhospitalized Patients

JAMA : the journal of the American Medical Association, 2022-02, Vol.327 (7), p.617

2022

Link zum Volltext

Verfügbarkeit prüfen

Single-Pill Combination Regimens for Treatment of HIV-1 Infection

The New England journal of medicine, 2014-07, Vol.371 (3), p.248-259

2014

Link zum Volltext

Verfügbarkeit prüfen

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

PLoS pathogens, 2017-04, Vol.13 (4), p.e1006285-e1006285

2017

Link zum Volltext

Verfügbarkeit prüfen

Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies

Clinical infectious diseases, 2022-03, Vol.74 (5), p.865-870

2022

Link zum Volltext

Verfügbarkeit prüfen

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

PLoS medicine, 2010-08, Vol.7 (8), p.e1000321

2010

Link zum Volltext

Verfügbarkeit prüfen

Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome

Journal of Virology, 2011-07, Vol.85 (14), p.7256-7263

2011

Link zum Volltext

Verfügbarkeit prüfen

Mild or Moderate Covid-19

The New England journal of medicine, 2020-10, Vol.383 (18), p.1757-1766

2020

Link zum Volltext

Verfügbarkeit prüfen

Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

Clinical infectious diseases, 2009-02, Vol.48 (3), p.350-361

2009

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment Levels of Soluble Cellular Receptors and Interleukin-6 Are Associated with HIV Disease Progression in Subjects Treated with Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2010-06, Vol.201 (12), p.1796-1805

2010

Link zum Volltext

Verfügbarkeit prüfen

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

PLoS pathogens, 2017-09, Vol.13 (9), p.e1006629-e1006629

2017

Link zum Volltext

Verfügbarkeit prüfen

Treating Acute Covid-19 — Final Chapters Still Unwritten

The New England journal of medicine, 2024-04, Vol.390 (13), p.1234-1236

2024

Link zum Volltext

Verfügbarkeit prüfen

Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa

Health and quality of life outcomes, 2023-08, Vol.21 (1), p.1-94, Article 94

2023

Link zum Volltext

Verfügbarkeit prüfen

Update on Opportunistic Infections in the Era of Effective Antiretroviral Therapy

Infectious disease clinics of North America, 2014-09, Vol.28 (3), p.501-518

2014

Link zum Volltext

Verfügbarkeit prüfen

CD8 epitope escape and reversion in acute HCV infection

The Journal of experimental medicine, 2004-12, Vol.200 (12), p.1593-1604

2004

Link zum Volltext

Verfügbarkeit prüfen

Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa

PloS one, 2012-09, Vol.7 (9), p.e44793

2012

Link zum Volltext

Verfügbarkeit prüfen

Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management

JAMA : the journal of the American Medical Association, 2022-02, Vol.327 (5), p.427

2022

Link zum Volltext

Verfügbarkeit prüfen

Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

Frontiers in cellular and infection microbiology, 2022-02, Vol.12, p.757846-757846

2022

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Steatosis Is Associated with Fibrosis, Nucleoside Analogue Use, and Hepatitis C Virus Genotype 3 Infection in HIV-Seropositive Patients

Clinical infectious diseases, 2006-08, Vol.43 (3), p.365-372

2006

Link zum Volltext

Verfügbarkeit prüfen

Importance of global communication to combat global pandemics: Lessons from the HIV Online Provider Education programme

Southern African journal of HIV medicine, 2021, Vol.22 (1), p.1281-1281

2021

Link zum Volltext

Verfügbarkeit prüfen

When Epidemics Collide: Why People With Human Immunodeficiency Virus May Have Worse Coronavirus Disease 2019 Outcomes and Implications for Vaccination

Clinical infectious diseases, 2021-06, Vol.72 (12), p.e1030-e1034

2021

Link zum Volltext

Verfügbarkeit prüfen

The Selective Downregulation of Class I Major Histocompatibility Complex Proteins by HIV-1 Protects HIV-Infected Cells from NK Cells

Immunity (Cambridge, Mass.), 1999-06, Vol.10 (6), p.661-671

1999

Link zum Volltext

Verfügbarkeit prüfen

No Evidence for Decay of the Latent Reservoir in HIV-1—Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy

The Journal of infectious diseases, 2010-01, Vol.201 (2), p.293-296

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 531

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(452)
Mit Volltextzugriff
(457)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(530)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Multidimensional Challenge of Treating Coronavirus Disease 2019 (COVID-19): Remdesivir Is a Foot in the Door

Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

COVID-19 Therapeutics for Nonhospitalized Patients

Single-Pill Combination Regimens for Treatment of HIV-1 Infection

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome

Mild or Moderate Covid-19

Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

Pretreatment Levels of Soluble Cellular Receptors and Interleukin-6 Are Associated with HIV Disease Progression in Subjects Treated with Highly Active Antiretroviral Therapy

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

Treating Acute Covid-19 — Final Chapters Still Unwritten

Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa

Update on Opportunistic Infections in the Era of Effective Antiretroviral Therapy

CD8 epitope escape and reversion in acute HCV infection

Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa

HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management

Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients

Hepatic Steatosis Is Associated with Fibrosis, Nucleoside Analogue Use, and Hepatitis C Virus Genotype 3 Infection in HIV-Seropositive Patients

Importance of global communication to combat global pandemics: Lessons from the HIV Online Provider Education programme

When Epidemics Collide: Why People With Human Immunodeficiency Virus May Have Worse Coronavirus Disease 2019 Outcomes and Implications for Vaccination

The Selective Downregulation of Class I Major Histocompatibility Complex Proteins by HIV-1 Protects HIV-Infected Cells from NK Cells

No Evidence for Decay of the Latent Reservoir in HIV-1—Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy

Suchergebnisse filtern